SABS: SAB Biotherapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
SAB Biotherapeutics muntazam davlat to'lovlarini kafolatlaydigan maxsus antitanachi sintezi tizimiga tayanadi. GURU.Markets tahlillari o'sishga bog'liq P/E ko'rsatkichini taqdim etadi, bunda 0.00 belgisi joriy holatni ko'rsatadi. Kompaniya diabet va infeksiyalarga qarshi ishlanmalarni kengaytirmoqda, ammo moliyaviy muvaffaqiyat FDA tasdig'iga va biomanufakturing yuqori xarajatlarini yengib o'tishga bog'liq.
SAB Biotherapeutics (SABS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati SAB Biotherapeutics|SABS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi sabbiotherapeutics.com|SABS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar SAB Biotherapeutics, Inc|SABS - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi SAB Biotherapeutics|Tezkor likvidlik koeffitsiyenti sabbiotherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
SABS - Sof foyda|Kutilayotgan foyda SAB Biotherapeutics|SABS - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori SAB Biotherapeutics Inc|SABS - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati SAB Biotherapeutics, Inc|SABS - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda SAB Biotherapeutics|SABS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi sabbiotherapeutics.com|SABS - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi SAB Biotherapeutics
Kompaniyaning umumiy tahlili:SABS - SAB Biotherapeutics Inc.
SAB Biotherapeutics (SABS) hozirda tadqiqot va ishlanmalarga (R&D) e'tibor qaratgan bo'lib, bozorga ta'sir ko'rsatish uchun o'z antitelalari sertifikatlashini kutmoqda. P/E va o'sish sur'atlarining ushbu taqqoslovi P/E koeffitsientini prognoz qilingan foyda o'sishiga bo'lish orqali normallashtiradi. Birga solishtirganda pastroq qiymatlar aktivning o'z salohiyatiga nisbatan qadrsizlanganini ko'rsatadi. Ushbu grafik tahlili istiqbolli "raketalar"ni erta bosqichda aniqlash imkonini beradi. Biroq, haddan tashqari minimal qiymat tizimli biznes risklaridan signal berishi mumkin.
SAB Biotherapeutics raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Pharvaris Pharma PHVS|ABCL: PEG multiplikatori|tourmalinebio.com (TRML) - PEG multiplikatori|PGEN (Precigen) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|Gossamer Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharma KALV|Septerna Corp (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Pieris Corp (PVLA)|Narx-foyda va o‘sish multiplikatori SVRA|RIGL (rigel.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori ANAB|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENGN (enGene Bio)|rapt.com (RAPT) - O‘sish sur’atiga tuzatilgan narx-foyda|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|KYTX: PEG multiplikatori|Tiziana Life Sciences Ltd. (TLSA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|Ventyx Biosciences, Inc - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori THTX|AVTX - O‘sish sur’atiga tuzatilgan narx-foyda|Eledon Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Agenus, Inc. AGEN|CLYM: Narx-foyda va o‘sish multiplikatori|zurabio.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ATYR: PEG multiplikatori|ADAG - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|IMA (ImageneBio) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Shattuck Therapeutics (STTK)|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati connectbiopharm.com|Narxning foydaga va o‘sish sur’atiga nisbati Immunic IMUX|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Atara Biotherapeutics, Inc. (ATRA)|InflaRx GmbH - PEG multiplikatori|XFOR - PEG multiplikatori|ACET: PEG multiplikatori|CELU (Celularity) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|barinthusbio.com (BRNS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Kezar Life Sciences, Inc. (KZR)|AKTX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GeoVax Labs, Inc. - PEG multiplikatori|EDSA - PEG multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|PEG multiplikatori affimed.com (AFMD)|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGM Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|TCBP - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|THRD (Third Harmonic Bio) - PEG multiplikatori
